Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia

American Journal of Cardiology

Volumn 104, Issue 5, 2009, Pages 671-677

  Spector, Peter ^a   Reynolds, Matthew R ^b   Calkins, Hugh ^c   Sondhi, Manu ^d   Xu, Yingxin ^d   Martin, Amber ^d   Williams, Catherine J ^d   Sledge, Isabella ^d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; EMBASE; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HUMAN; MEDLINE; MORTALITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT RESPONSE;

ATRIAL FLUTTER; CATHETER ABLATION; HUMANS; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TREATMENT OUTCOME;

EID: 68849131994     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.040     Document Type: Article

References (26)

1. Agency for Healthcare Research and Quality. HCUPnet. http://hcupnet.ahrq.gov Accessed June 12, 2008
2. Kay G.N., Epstein A.E., Dailey S.M., and Plumb V.J. Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol 4 (1993) 371-389
3. Schumacher B., Pfeiffer D., Tebbenjohanns J., Lewalter T., Jung W., and Luderitz B. Acute and long-term effects of consecutive radiofrequency applications on conduction properties of the subeustachian isthmus in type I atrial flutter. J Cardiovasc Electrophysiol 9 (1998) 152-163
4. Tai C.T., Chen S.A., Chiang C.E., Lee S.H., Wen Z.C., Huang J.L., Chen Y.J., Yu W.C., Feng A.N., Lin Y.J., Ding Y.A., and Chang M.S. Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 9 (1998) 115-121
5. Calkins H., Epstein A., Packer D., Arria A.M., Hummel J., Gilligan D.M., Trusso J., Carlson M., Luceri R., Kopelman H., Wilber D., Wharton J.M., and Stevenson W. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy. J Am Coll Cardiol 35 (2000) 1905-1914
6. Kuck K.H., Schluter M., Geiger M., Siebels J., and Duckeck W. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 337 (1991) 1557-1561
7. Kimman G.P., van Hemel N.M., Jessurun E.R., van Dessel P.F., Kelder J.C., Defauw J.J., and Guiraudon G.M. Comparison of late results of surgical or radiofrequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. Eur Heart J 20 (1999) 527-534
8. Salerno J.A., Storti C., De Ponti R., Zardini M., Longobardi M., Ferrari A., and Massacci E. Transcatheter ablation by radiofrequency in paroxysmal atrioventricular junctional reentrant tachycardia. The role of mapping. New Trends Arrhythm 7 (1991) 367-378
9. Lesh M.D., Van Hare G.F., Schamp D.J., Chien W., Lee M.A., Griffin J.C., Langberg J.J., Cohen T.J., Lurie K.G., and Scheinman M.M. Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol 19 (1992) 1303-1309
10. Hindricks G., and The Multicentre European Radiofrequency Survey (MERFS) Investigators of the Working Group on Arrhythmias of the European Society of Cardiology. The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 14 (1993) 1644-1653
11. Scheinman M.M. Nonpharmacologic management of supraventricular tachycardia. Am J Geriatr Cardiol 9 (2000) 159-161
12. Scheinman M.M., and Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 23 (2000) 1020-1028
13. Gallagher J.J., Gilbert M., Svenson R.H., Sealy W.C., Kasell J., and Wallace A.G. Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction. Circulation 51 (1975) 767-785
14. Scheinman M.M., and Evans-Bell T. Catheter ablation of the atrioventricular junction: a report of the percutaneous mapping and ablation registry. Circulation 70 (1984) 1024-1029
15. Hohnloser S.H., and Zabel M. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 70 suppl (1992) 3A-10A
16. Singh S., Zoble R.G., Yellen L., Brodsky M.A., Feld G.K., Berk M., and Billing Jr. C.B. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Circulation 102 (2000) 2385-2390
17. Da Costa A., Thévenin J., Roche F., Romeyer-Bouchard C., Abdellaoui L., Messier M., Denis L., Faure E., Gonthier R., Kruszynski G., Pages J.M., Bonijoly S., Lamaison D., Defaye P., Barthélemy J.C., Gouttard T., Isaaz K., and Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) Trial of Atrial Flutter Investigators. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) Trial on Atrial Flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 114 (2006) 1676-1681
18. Natale A., Newby K.H., Pisano E., Leonelli F., Fanelli R., Potenza D., Beheiry S., and Tomassoni G. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 35 (2000) 1898-1904
19. Blomstrom-Lundqvist C., Scheinman M.M., Aliot E.M., Alpert J.S., Calkins H., Camm A.J., Campbell W.B., Haines D.E., Kuck K.H., Lerman B.B., Miller D.D., Shaeffer Jr. C.W., Stevenson W.G., Tomaselli G.F., Antman E.M., Smith Jr. S.C., Alpert J.S., Faxon D.P., Fuster V., Gibbons R.J., Gregoratos G., Hiratzka L.F., Hunt S.A., Jacobs A.K., Russell Jr. R.O., Priori S.G., Blanc J.-J., Budaj A., Burgos E.F., Cowie M., Deckers J.W., Garcia M.A.A., Klein W.W., Lekakis J., Lindahl B., Mazzotta G., Morais J.C.A., Oto A., Smiseth O., and Trappe H.-J. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 108 (2003) 1871-1909
20. Mauritson D.R., Winniford M.D., Walker W.S., Rude R.E., Cary J.R., and Hillis L.D. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial. Ann Intern Med 96 (1982) 409-412
21. Winniford M.D., Fulton K.L., and Hillis L.D. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 54 (1984) 1138-1139
22. Anderson J.L., Jolivette D.M., and Fredell P.A. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Am J Cardiol 62 suppl (1988) 62D-66D
23. UK Propafenone PSVT Study Group. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 92 (1995) 2550-2557
24. Pritchett E.L., McCarthy E.A., and Wilkinson W.E. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 114 (1991) 539-544
25. Wanless R.S., Anderson K., Joy M., and Joseph S.P. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J 133 (1997) 441-446
26. Tendera M., Wnuk-Wojnar A.M., Kulakowski P., Malolepszy J., Kozlowski J.W., Krzeminska-Pakula M., Szechinski J., Droszcz W., Kawecka-Jaszcz K., Swiatecka G., Ruzyllo W., and Graff O. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J 142 (2001) 93-98